Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Professor Chao Zhang's team at Zhujiang Hospital, Southern Medical University, has developed a novel DNA nanomachine-based drug delivery and release strategy aimed at overcoming chemoresistance in ...
The firm received FDA feedback on the design of registrational studies of VS-7375, while it awaits new data for Avmapki Fakzynja.
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — leaving nearly 70% of annual cancer cases and ...
BrYet US, Inc. (“BrYet”) — a biotechnology innovator focused on developing curative therapies for advanced cancers — ...
Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and ...
A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results